|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phosphocreatine inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein]]; Phosphocreatine inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:37648050 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP ISO |
Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of BAX protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in increased expression of BAX protein]; Phosphocreatine inhibits the reaction [Streptozocin results in increased expression of BAX protein] Phosphocreatine inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein] |
CTD |
PMID:34358621 PMID:34455488 PMID:37597758 PMID:37648050 PMID:39043266 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
multiple interactions decreases expression |
EXP |
Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of BBC3 mRNA]; Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of BBC3 protein] Phosphocreatine results in decreased expression of BBC3 mRNA; Phosphocreatine results in decreased expression of BBC3 protein |
CTD |
PMID:37597758 |
|
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP ISO |
Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased expression of BCL2 protein]; Phosphocreatine inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] Phosphocreatine inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] |
CTD |
PMID:34455488 PMID:37648050 PMID:39043266 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP ISO |
7-oxozeanol inhibits the reaction [Phosphocreatine inhibits the reaction [Doxorubicin results in increased cleavage of CASP3 protein]]; Phosphocreatine inhibits the reaction [Doxorubicin results in increased cleavage of CASP3 protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased expression of CASP3 protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in increased expression of CASP3 protein modified form]; Phosphocreatine inhibits the reaction [Streptozocin results in decreased expression of CASP3 protein]; Phosphocreatine inhibits the reaction [Streptozocin results in increased expression of CASP3 protein modified form] Phosphocreatine inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 protein] |
CTD |
PMID:34358621 PMID:34455488 PMID:37597758 PMID:37648050 PMID:39043266 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP ISO |
Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased expression of CASP9 protein]; Phosphocreatine inhibits the reaction [Streptozocin results in decreased expression of CASP9 protein] Phosphocreatine inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP9 protein] |
CTD |
PMID:34455488 PMID:37648050 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccn2 |
cellular communication network factor 2 |
multiple interactions |
EXP |
Phosphocreatine promotes the reaction [Doxorubicin results in decreased expression of CTGF mRNA] |
CTD |
PMID:37597758 |
|
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ctnnd1 |
catenin delta 1 |
multiple interactions |
EXP |
Phosphocreatine promotes the reaction [Doxorubicin results in decreased expression of CTNND1 mRNA] |
CTD |
PMID:37597758 |
|
NCBI chr 3:90,090,025...90,141,247
Ensembl chr 3:69,683,313...69,734,516
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
EXP |
Phosphocreatine inhibits the reaction [Doxorubicin affects the localization of CYCS protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in increased expression of CYCS protein]; Phosphocreatine inhibits the reaction [Streptozocin results in increased expression of CYCS protein] |
CTD |
PMID:34455488 PMID:39043266 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
EXP |
Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of FOXO3 protein] |
CTD |
PMID:34358621 |
|
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
Phosphocreatine inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased phosphorylation of GSK3B protein]; Phosphocreatine inhibits the reaction [Streptozocin results in decreased phosphorylation of GSK3B protein] |
CTD |
PMID:34455488 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
multiple interactions |
EXP |
Phosphocreatine promotes the reaction [Doxorubicin results in decreased expression of IGF1R mRNA] |
CTD |
PMID:37597758 |
|
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP |
Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased secretion of INS1 protein]; Phosphocreatine inhibits the reaction [Streptozocin results in decreased secretion of INS1 protein] |
CTD |
PMID:34455488 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Irs1 |
insulin receptor substrate 1 |
multiple interactions |
EXP |
Phosphocreatine inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of IRS1 protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased phosphorylation of IRS1 protein]; Phosphocreatine inhibits the reaction [Streptozocin results in decreased phosphorylation of IRS1 protein] |
CTD |
PMID:34455488 |
|
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Lpl |
lipoprotein lipase |
multiple interactions |
EXP |
Phosphocreatine inhibits the reaction [Dietary Fats results in decreased activity of LPL protein] |
CTD |
PMID:37648050 |
|
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Map3k7 |
mitogen activated protein kinase kinase kinase 7 |
multiple interactions |
EXP |
7-oxozeanol inhibits the reaction [Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of MAP3K7 protein]]; Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of MAP3K7 protein]; Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of MAP3K7 protein] |
CTD |
PMID:34358621 |
|
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
|
|
G |
Mapk7 |
mitogen-activated protein kinase 7 |
decreases expression multiple interactions |
EXP |
Phosphocreatine results in decreased expression of MAPK7 mRNA Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of MAPK7 mRNA] |
CTD |
PMID:37597758 |
|
NCBI chr10:46,669,721...46,675,768
Ensembl chr10:46,170,167...46,176,267
|
|
G |
Mapt |
microtubule-associated protein tau |
decreases abundance multiple interactions |
ISO |
MAPT protein mutant form results in decreased abundance of Phosphocreatine PF-06840003 inhibits the reaction [MAPT protein mutant form results in decreased abundance of Phosphocreatine] |
CTD |
PMID:39172838 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mir143 |
microRNA 143 |
multiple interactions increases expression |
EXP |
Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of MIR143 mRNA] Phosphocreatine results in increased expression of MIR143 mRNA |
CTD |
PMID:37597758 |
|
NCBI chr18:57,371,349...57,371,453
Ensembl chr18:55,101,006...55,101,110
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
Phosphocreatine affects the reaction [Doxorubicin affects the expression of NFE2L2 protein]; Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein] |
CTD |
PMID:34358621 PMID:37597758 PMID:39043266 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
decreases expression multiple interactions |
EXP |
Phosphocreatine results in decreased expression of PDGFRA mRNA Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of PDGFRA mRNA] |
CTD |
PMID:37597758 |
|
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions |
EXP |
Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of PPARGC1A protein] |
CTD |
PMID:39043266 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ppid |
peptidylprolyl isomerase D |
multiple interactions |
EXP |
Phosphocreatine inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPID protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in increased expression of PPID protein]; Phosphocreatine inhibits the reaction [Streptozocin results in increased expression of PPID protein] |
CTD |
PMID:34455488 |
|
NCBI chr 2:167,025,985...167,037,998
Ensembl chr 2:164,727,779...164,740,221
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases expression |
EXP |
Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of PTGS2 mRNA] Phosphocreatine results in decreased expression of PTGS2 mRNA |
CTD |
PMID:37597758 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
multiple interactions |
EXP |
Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of RIPK3 protein] |
CTD |
PMID:34358621 |
|
NCBI chr15:33,253,071...33,262,025
Ensembl chr15:29,283,145...29,292,121
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
EXP |
Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein] |
CTD |
PMID:37597758 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sod3 |
superoxide dismutase 3 |
multiple interactions |
EXP |
Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of SOD3 protein] |
CTD |
PMID:34358621 |
|
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases response to substance multiple interactions |
EXP |
STAT3 protein results in increased susceptibility to Phosphocreatine Phosphocreatine inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased phosphorylation of STAT3 protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in increased phosphorylation of STAT3 protein]; Phosphocreatine inhibits the reaction [Streptozocin results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:34455488 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
|
|